Trailing-twelve-month (TTM) revenue is $16.10 Million with a year-over-year growth of +145.21%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,356,609 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-19 |
| Q4 FY2025Period ended 2025-12-31 | $3,209,966 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-22 |
| Q1 FY2026Period ended 2026-03-31 | $5,211,447 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-22 |
| Q2 FY2026Period ended 2026-06-30 | $6,321,843 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-14 |
| TTM revenue | $16,099,865 |
Current P/S: $17,424,843 market capitalization ÷ $16,099,865 TTM revenue = 1.08x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:29:57.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $6.32M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:32:47.165Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Asia | $260,131 | N/A |
| North America | $6M | $8M |
$16.10M
$16.10 Million
+145.21%
vs. $6.57M a year ago (TTM)
+63.03%
5 Year compound annual growth rate
1 Year
+145.21%
3 Year
+54.79%
5 Year
+63.03%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $8.09M | +$2.17M | +36.54% |
| 2024 | $5.93M | +$420,394 | +7.63% |
| 2023 | $5.51M | +$2.27M | +69.98% |
| 2022 | $3.24M | +$960,451 | +42.12% |
| 2021 | $2.28M | +$1.49M | +187.49% |
| 2020 |
TTM Growth
+145.21%
3-Year CAGR
+54.79%
5-Year CAGR
+63.03%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:32:47.165Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $793,088 |
| +$175,267 |
| +28.37% |
| 2019 | $617,821 | +$306,726 | +98.60% |
| 2017 | $311,095 | +$262,926 | +545.84% |
